Johanna Friedl-Naderer
Equibles does not estimate personal net worth.
Get an email with a short summary when Vir Biotechnology, Inc. publishes a filing, an earnings call transcript or a press release.
Get VIR alertsAbout Johanna Friedl-Naderer
Johanna Friedl-Naderer is recorded as COO at Vir Biotechnology, Inc. (VIR). The proxy statement of Vir Biotechnology, Inc. reports total compensation of $4,395,064 for Johanna Friedl-Naderer in fiscal 2023, including a base salary of $604,640. Disclosed compensation is on record for 2 fiscal years. Vir Biotechnology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vir Biotechnology, Inc. includes Marianne De Backer, MSc, Ph.D., MBA (CEO and Board Member), Aziz Sawaf (CFO), Brent Sabatini (CFO) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at Vir Biotechnology, Inc.
- Marianne De Backer, MSc, Ph.D., MBA CEO, Board Member
- Aziz Sawaf CFO
- Brent Sabatini CFO
- Howard Horn CFO
- Jason O'Byrne CFO
- Michael Kamarck CTO
- Vanina de Verneuil General Counsel
- Elliott Sigal Board Member
- Janet Napolitano Board Member
- Robert More Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Vir Biotechnology, Inc. (VIR) | Former Executive Vice President and Chief Operating Officer | $604,640 | $4,395,064 |
| 2022 | Vir Biotechnology, Inc. (VIR) | Former Executive Vice President and Chief Operating Officer | $444,396 | $5,040,031 |
Recent activity
No call appearances or filed executive changes recorded yet.